【Goldman Sachs (China) Securities Company Limited&Goldman Sachs (Asia) L.L.C.】【202610】Gan & Lee Pharmaceuticals Co. (603087.SS) GZR4's Phase III success highlights its competitive potential； TP up to Rmb78； Buy-9页

Goldman Sachs (China) Securities Company Limited&Goldman Sachs (Asia) L.L.C. 卫生和社会工作 2026年 PDF 9.51 MB

胰岛素类似物 糖尿病药物 GZR4 临床试验 Novo Nordisk